Exact Mass: 538.2543
Exact Mass Matches: 538.2543
Found 500 metabolites which its exact mass value is equals to given mass value 538.2543
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Physalolactone
Physalolactone is found in fruits. Physalolactone is a constituent of Physalis peruviana (Cape gooseberry) Found in cheese and liver
Prolyl-phenylalanyl-arginine-4-nitroanilide
Physalolactone
6beta-O-(8-oxo-2,6-dimethyl-<2E,6E>-octadienoyl)boschnaloside|6beta-O-(8-oxo-2,6-dimethyl-[2E,6E]-octadienoyl)boschnaloside
5-Cinnamoyl-9-O-acetylphototaxicin I|5-E-cinnamoyl-10-acetylphototaxicin I
bipindogenin-3beta-O-(beta-D-riboside)|bipindogenin-3beta-O-
(3R,5R)-3,5-Dihydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)heptane 3-O-??-D-glucopyranoside
1beta,2alpha,9alpha-trihydroxy-10beta-acetoxy-5alpha-cinnamoyloxy-3,11-cyclotaxa-4(20)-en-13-one|5-Cinnamoyl-10-acetylphototaxicin-I|5alpha-cinnamoyl-9alpha-acetylphototaxicin I
(-)-secoisolariciresinol monomethyl ether 4-O-beta-D-glucopyranoside|tinosposide A
(20SR,22RS)-5alpha,6beta,14alpha,15alpha,17beta,20,27-heptahydroxy-1-oxowith-24-enolide|coagulin S
(20S,22S,23S,24S,25S,26S)-5alpha-chloro-12alpha,22,23,26,24,25-triepoxy-6beta,12beta,17beta,26-tetrahydroxyergosta-2-en-1-one|jaborosalactol 25
3R,5R,6S,7E,9R-megastigman-7-en-3,5,6,9-tetrol-9-O-beta-D-apiofuranosyl-(1?2)-beta-D-glucopyranoside
(12E,2S,3S,4R,5R,6S,9S,11R,15R)-3-benzoyloxy-5,15-diacetoxy-6,17-epoxylathyra-12-en-14-one
12alpha-methoxyl,5alpha,14beta-dihydroxy-1alpha,6alpha,7beta-triacetoxycass-13(15)-en-16,12-olide|neocaesalpin MP
3-deisobutyryl-3-O-methacryloylgranatumin H|granatumin I|methyl rel-(4R,4aR,6aS,7R,8S,10R,11S,12bS)-4-(furan-3-yl)-1,4,4a,5,6,6a,7,8,9,10,11,12b-dodecahydro-4a,7,9,9-tetramethyl-10-[(2-methyl-1-oxoprop-2-en-1-yl)oxy]-2,13-dioxo-7,11-methano-2H-cycloocta[3,4]benzo[1,2-c]pyran-8-acetate
10beta-hydroxy-19-norperiplogenin-3beta-O-alpha-L-rhamnopyranose|toxicarioside M
1alpha,6alpha,7beta-triacetoxy-5alpha-hydroxy-16,16-dimethoxy-12-oxocassa-13(14)-diene|caesalpin C
3-hydroxymethyl-5-(3-hydroxypropyl)-7-methoxy-2-{3-methoxy-4-[1-(3,4-dimethoxybenzyl)-2-hydroxyethyl]phenyl}-2,3-dihydrobenzofuran
3-oxo-alpha-ionol-O-beta-D-tetraacetylglucopyranoside
Gln Tyr Thr Lys
Tyr Asn Asp Lys
Tyr Ser Asn Arg
Tyr Gln Thr Lys
Asp Asn Tyr Lys
5QL8Q0680S
Cephaeline dihydrochloride is a selective CYP2D6 inhibtor with an IC50 of 121 μM.
C28H42O10_4H-Cyclopenta[a]cyclopropa[f]cycloundecen-4-one, 4a-(acetyloxy)-9-[(hexopyranosyloxy)methyl]-1,1a,4a,5,6,7,7a,10,11,11a-decahydro-7-hydroxy-1,1,3,6-tetramethyl-, (8E)
Cys Phe Asn Arg
Cys Phe Arg Asn
Cys Asn Phe Arg
Cys Asn Arg Phe
Cys Arg Phe Asn
Cys Arg Asn Phe
Asp Lys Asn Tyr
Asp Lys Tyr Asn
Asp Asn Lys Tyr
Asp Tyr Lys Asn
Asp Tyr Asn Lys
Glu Phe Phe Pro
Glu Phe Ile Met
Glu Phe Leu Met
Glu Phe Met Ile
Glu Phe Met Leu
Glu Phe Pro Phe
Glu Ile Phe Met
Glu Ile Met Phe
Glu Leu Phe Met
Glu Leu Met Phe
Glu Met Phe Ile
Glu Met Phe Leu
Glu Met Ile Phe
Glu Met Leu Phe
Glu Pro Phe Phe
Phe Cys Asn Arg
Phe Cys Arg Asn
Phe Glu Phe Pro
Phe Glu Ile Met
Phe Glu Leu Met
Phe Glu Met Ile
Phe Glu Met Leu
Phe Glu Pro Phe
Phe Phe Glu Pro
Phe Phe Pro Glu
Phe His His Val
Phe His Val His
Phe Ile Glu Met
Phe Ile Met Glu
Phe Ile Pro Tyr
Phe Ile Tyr Pro
Phe Lys Met Asn
Phe Lys Asn Met
Phe Leu Glu Met
Phe Leu Met Glu
Phe Leu Pro Tyr
Phe Leu Tyr Pro
Phe Met Glu Ile
Phe Met Glu Leu
Phe Met Ile Glu
Phe Met Lys Asn
Phe Met Leu Glu
Phe Met Asn Lys
Phe Asn Cys Arg
Phe Asn Lys Met
Phe Asn Met Lys
Phe Asn Arg Cys
Phe Pro Glu Phe
Phe Pro Phe Glu
Phe Pro Ile Tyr
Phe Pro Leu Tyr
Phe Pro Tyr Ile
Phe Pro Tyr Leu
Phe Arg Cys Asn
Phe Arg Asn Cys
Phe Val His His
Phe Tyr Ile Pro
Phe Tyr Leu Pro
Phe Tyr Pro Ile
Phe Tyr Pro Leu
His Phe His Val
His Phe Val His
His His Phe Val
His His Val Phe
His Val Phe His
His Val His Phe
Ile Glu Phe Met
Ile Glu Met Phe
Ile Phe Glu Met
Ile Phe Met Glu
Ile Phe Pro Tyr
Ile Phe Tyr Pro
Ile Met Glu Phe
Ile Met Phe Glu
Ile Pro Phe Tyr
Ile Pro Tyr Phe
Ile Tyr Phe Pro
Ile Tyr Pro Phe
Lys Asp Asn Tyr
Lys Asp Tyr Asn
Lys Phe Met Asn
Lys Phe Asn Met
Lys Met Phe Asn
Lys Met Asn Phe
Lys Asn Asp Tyr
Lys Asn Phe Met
Lys Asn Met Phe
Lys Asn Tyr Asp
Lys Gln Thr Tyr
Lys Gln Tyr Thr
Lys Thr Gln Tyr
Lys Thr Tyr Gln
Lys Tyr Asp Asn
Lys Tyr Asn Asp
Lys Tyr Gln Thr
Lys Tyr Thr Gln
Leu Asp Tyr Glu
Leu Glu Asp Tyr
Leu Glu Phe Met
Leu Glu Met Phe
Leu Glu Tyr Asp
Leu Phe Glu Met
Leu Phe Met Glu
Leu Phe Pro Tyr
Leu Phe Tyr Pro
Leu Met Glu Phe
Leu Met Phe Glu
Leu Pro Phe Tyr
Leu Pro Tyr Phe
Leu Tyr Asp Glu
Leu Tyr Glu Asp
Leu Tyr Phe Pro
Leu Tyr Pro Phe
Met Glu Phe Ile
Met Glu Phe Leu
Met Glu Ile Phe
Met Glu Leu Phe
Met Phe Glu Ile
Met Phe Glu Leu
Met Phe Ile Glu
Met Phe Lys Asn
Met Phe Leu Glu
Met Phe Asn Lys
Met Ile Glu Phe
Met Ile Phe Glu
Met Lys Phe Asn
Met Lys Asn Phe
Met Leu Glu Phe
Met Leu Phe Glu
Met Asn Phe Lys
Met Asn Lys Phe
Asn Cys Phe Arg
Asn Cys Arg Phe
Asn Asp Lys Tyr
Asn Asp Tyr Lys
Asn Phe Cys Arg
Asn Phe Lys Met
Asn Phe Met Lys
Asn Phe Arg Cys
Asn Lys Asp Tyr
Asn Lys Phe Met
Asn Lys Met Phe
Asn Lys Tyr Asp
Asn Met Phe Lys
Asn Met Lys Phe
Asn Arg Cys Phe
Asn Arg Phe Cys
Asn Arg Ser Tyr
Asn Arg Tyr Ser
Asn Ser Arg Tyr
Asn Ser Tyr Arg
Asn Tyr Asp Lys
Asn Tyr Lys Asp
Asn Tyr Arg Ser
Asn Tyr Ser Arg
Pro Glu Phe Phe
Pro Phe Glu Phe
Pro Phe Phe Glu
Pro Phe Ile Tyr
Pro Phe Leu Tyr
Pro Phe Tyr Ile
Pro Phe Tyr Leu
Pro Ile Phe Tyr
Pro Ile Tyr Phe
Pro Leu Phe Tyr
Pro Leu Tyr Phe
Pro Pro Tyr Tyr
Pro Tyr Phe Ile
Pro Tyr Phe Leu
Pro Tyr Ile Phe
Pro Tyr Leu Phe
Pro Tyr Pro Tyr
Pro Tyr Tyr Pro
Gln Lys Thr Tyr
Gln Lys Tyr Thr
Gln Gln Thr Tyr
Gln Gln Tyr Thr
Gln Thr Lys Tyr
Gln Thr Gln Tyr
Gln Thr Tyr Lys
Gln Thr Tyr Gln
Gln Tyr Lys Thr
Gln Tyr Gln Thr
Gln Tyr Thr Gln
Arg Cys Phe Asn
Arg Cys Asn Phe
Arg Phe Cys Asn
Arg Phe Asn Cys
Arg Asn Cys Phe
Arg Asn Phe Cys
Arg Asn Ser Tyr
Arg Asn Tyr Ser
Arg Ser Asn Tyr
Arg Ser Tyr Asn
Arg Tyr Asn Ser
Arg Tyr Ser Asn
Ser Asn Arg Tyr
Ser Asn Tyr Arg
Ser Arg Asn Tyr
Ser Arg Tyr Asn
Ser Tyr Asn Arg
Ser Tyr Arg Asn
Thr Lys Gln Tyr
Thr Lys Tyr Gln
Thr Gln Lys Tyr
Thr Gln Gln Tyr
Thr Gln Tyr Lys
Thr Gln Tyr Gln
Thr Tyr Lys Gln
Thr Tyr Gln Lys
Thr Tyr Gln Gln
Val Glu Glu Tyr
Val Glu Tyr Glu
Val Phe His His
Val His Phe His
Val His His Phe
Val Tyr Glu Glu
Tyr Asp Glu Ile
Tyr Asp Glu Leu
Tyr Asp Ile Glu
Tyr Asp Lys Asn
Tyr Asp Leu Glu
Tyr Asp Asn Lys
Tyr Phe Ile Pro
Tyr Phe Leu Pro
Tyr Phe Pro Ile
Tyr Phe Pro Leu
Tyr Ile Phe Pro
Tyr Ile Pro Phe
Tyr Lys Asp Asn
Tyr Lys Asn Asp
Tyr Lys Gln Thr
Tyr Lys Thr Gln
Tyr Leu Phe Pro
Tyr Leu Pro Phe
Tyr Asn Lys Asp
Tyr Asn Arg Ser
Tyr Asn Ser Arg
Tyr Pro Phe Ile
Tyr Pro Phe Leu
Tyr Pro Ile Phe
Tyr Pro Leu Phe
Tyr Pro Pro Tyr
Tyr Pro Tyr Pro
Tyr Gln Lys Thr
Tyr Gln Gln Thr
Tyr Gln Thr Gln
Tyr Arg Asn Ser
Tyr Arg Ser Asn
Tyr Ser Arg Asn
Tyr Thr Lys Gln
Tyr Thr Gln Lys
Tyr Thr Gln Gln
Tyr Tyr Pro Pro
TMC-1C
A polyene antibiotic that is TMC-1A in which the 2,4-dimethyloct-2-enoyl group has been replaced by an (E,E)-4,6-dimethyldeca-2,4-dienoyl group. TMC-1C is an antitumour antibiotic isolated from Streptomyces sp. A-230.
Physalolactone
1,1-[(5E)-5-Methyl-7-oxo-5-undecene-1,11-diyl] Bis
1,3,3-trimethyl-2-[2-[3-[2-(1,3,3-trimethylindol-1-ium-2-yl)ethenyl]-2H-pyran-5-ylidene]ethylidene]indole,tetrafluoroborate
Pentolinium Tartrate
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D005730 - Ganglionic Blockers D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Beclomethasone Dipropionate Monohydrate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
(4R,5S,6S,7R)-1,3-dibenzyl-5,6-dihydroxy-4,7-bis(phenoxymethyl)-1,3-diazepan-2-one
Prolyl-phenylalanyl-arginine-4-nitroanilide
[(3E,10E)-13-hydroxy-3,6,6,14-tetramethyl-2-oxo-10-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-1-tricyclo[10.3.0.05,7]pentadeca-3,10-dienyl] acetate
14-hydro-15-hydroxyajugachin A
A diterpenoid isolated from Ajuga bracteosa and has been shown to exhibit antifeedant activity.
1-[(6,7-dimethoxy-2-oxo-1H-quinolin-3-yl)methyl]-1-[2-(3-methylphenyl)ethyl]-3-[3-(4-morpholinyl)propyl]thiourea
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[[(4-methoxyanilino)-oxomethyl]-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]cyclopropanecarboxamide
N-[[(4R,5R)-8-(2-cyclopentylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-phenylacetamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[[(4-methoxyanilino)-oxomethyl]-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]cyclopropanecarboxamide
N-[[(4S,5R)-8-(2-cyclopentylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-phenylacetamide
N-[[(4S,5S)-8-(2-cyclopentylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-phenylacetamide
N-[[(4R,5S)-8-(2-cyclopentylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-phenylacetamide
N-[[(4R,5R)-8-(2-cyclopentylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-phenylacetamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[[(4-methoxyanilino)-oxomethyl]-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]cyclopropanecarboxamide
N-[[(4R,5S)-8-(2-cyclopentylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-phenylacetamide
N-[[(4S,5R)-8-(2-cyclopentylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-phenylacetamide
N-[[(4S,5S)-8-(2-cyclopentylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-phenylacetamide
8-[(2R,5R)-3-hydroxy-5-[4-[[(2R)-2-hydroxy-2-(4-hydroxyphenyl)ethyl]amino]-4-oxobutanoyl]oxy-6-methyloxan-2-yl]oxynonanoate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
(2E,4E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohex-1-en-1-yl]-4,6-dimethyldeca-2,4-dienamide
S-dodecanoyl-4-phosphopantetheine(2-)
An S-acyl-4-phosphopantetheine obtained by deprotonation of the phosphate OH groups of S-dodecanoyl-4-phosphopantetheine; major species at pH 7.3.
WAY-100635 (maleate)
WAY-100635 maleate is a potent and selective 5-hydroxytryptamine 1A (5-HT1A) receptor antagonist with an IC50 value of 0.91 nM and Ki value of 0.39 nM. WAY-100635 maleate has pIC50 values for 5-HT1A and α1-adrenergic receptors of 8.9 and 6.6, respectively. WAY-100635 maleate is also a potent dopamine D4 receptor agonist[1][2][3].
(1r,4r,5r,7s)-7-[(1s,2r,3as,3bs,5s,5ar,6s,9ar,9bs,11as)-5-chloro-1,2,5a,6-tetrahydroxy-9a,11a-dimethyl-9-oxo-2h,3h,3ah,3bh,4h,5h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-4-hydroxy-4,5-dimethyl-2-oxabicyclo[3.2.1]octan-3-one
(1s,2r,3ar,5r,11r,13as)-3a,11-bis(acetyloxy)-2,5,8,8,12-pentamethyl-4,9-dioxo-1h,2h,3h,5h,10h,11h,13ah-cyclopenta[12]annulen-1-yl benzoate
(1r,2s,4ar,5s,6r,8s,8ar)-5-[(2s,3as,5r,6ar)-5-ethoxy-hexahydrofuro[2,3-b]furan-2-yl]-2,8-bis(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
(2s)-8-{[(2s)-7-hydroxy-5-methoxy-2-phenyl-3,4-dihydro-2h-1-benzopyran-8-yl]methyl}-5-methoxy-6-methyl-2-phenyl-3,4-dihydro-2h-1-benzopyran-7-ol
8-(acetyloxy)-8a-[(acetyloxy)methyl]-5-{hexahydrofuro[2,3-b]furan-2-yl}-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-2-yl 2-methylpropanoate
[3,4,5-tris(acetyloxy)-6-{[4-(2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)but-3-en-2-yl]oxy}oxan-2-yl]methyl acetate
(1s,4as,5r,7r,7ar)-5-{[(3e,7z)-3,7-dimethyl-2,9-dioxonona-3,7-dien-1-yl]oxy}-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carbaldehyde
1-[4-(acetyloxy)-5-(2-methylprop-1-en-1-yl)-2-oxooxolan-3-ylidene]-10-(benzoyloxy)-4,8-dimethyldeca-4,8-dien-3-yl acetate
(2s,3r,4s,5r,6r)-2-{[(1s,3r,4r)-3,4-dihydroxy-4-[(1e,3r)-3-hydroxybut-1-en-1-yl]-3,5,5-trimethylcyclohexyl]oxy}-6-({[(2r,3s,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol
6-hydroxy-9-[3-({1-hydroxy-4-oxo-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-3-yl}methyl)-1h-indol-6-yl]-4-methyl-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one
(3ar,4r,6ar,8s,9ar,9br)-3,6,9-trimethylidene-2-oxo-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-4-yl (2r,3s)-2-hydroxy-3-methylpentanoate
(1s,4r,7r,9r)-9-(3-{[(3r,8ar)-1-hydroxy-4-oxo-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-3-yl]methyl}-1h-indol-6-yl)-6-hydroxy-4-methyl-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one
(1r,2s,3s,4ar,5s,6r,8s,8ar)-5-[(2r,3ar,6as)-hexahydrofuro[2,3-b]furan-2-yl]-8-(acetyloxy)-8a-[(acetyloxy)methyl]-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-2-yl 2-methylpropanoate
methyl 2-[(1r,2s)-2-[(1r,5r,6r,7r,7as)-6,7-bis(acetyloxy)-1-(furan-3-yl)-7a-methyl-4-methylidene-2,5,6,7-tetrahydro-1h-inden-5-yl]-2,6,6-trimethyl-5-oxocyclohex-3-en-1-yl]acetate
4-[(2s,3r,4r,5s)-5-(4-{[(1r,2s)-1-(3,4-dimethoxyphenyl)-1-hydroxypropan-2-yl]oxy}-3-methoxyphenyl)-3,4-dimethyloxolan-2-yl]-2-methoxyphenol
5-[(3,7-dimethyl-2,9-dioxonona-3,7-dien-1-yl)oxy]-7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carbaldehyde
(1s,4r,12s,14s,17z,29s)-12,29-dihydroxy-19,19-dimethyl-5-(2-methylbut-3-en-2-yl)-3,5,16,21-tetraazaheptacyclo[14.13.0.0³,¹⁴.0⁴,¹².0⁶,¹¹.0²⁰,²⁸.0²²,²⁷]nonacosa-6,8,10,17,20(28),22,24,26-octaene-2,15-dione
(1s,2r,3e,5r,7r,8r,10s,13r)-13-(acetyloxy)-2,7,10-trihydroxy-8,12,15,15-tetramethyl-9-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-3,11-dien-5-yl (2e)-3-phenylprop-2-enoate
(2r,3r,4s,5s,6r)-2-{[(3r,5r)-5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)heptan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1r,3r,5s,6ar,7r,8s,10s,10ar)-1,3-bis(acetyloxy)-10-hydroxy-7,8-dimethyl-7-[(2e)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl benzoate
n-[5-({7-hydroxy-3-[(1-hydroxy-3-methylbut-2-en-1-ylidene)amino]-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-2-yl}methyl)-2,6a-dimethyl-6-oxo-1ah,2h,6bh-oxireno[2,3-a]pyrrolizin-4-yl]-3-methylbut-2-enimidic acid
2-o-acetyl-5-o-cinnamoyltaxicin i
{"Ingredient_id": "HBIN006172","Ingredient_name": "2-o-acetyl-5-o-cinnamoyltaxicin i","Alias": "NA","Ingredient_formula": "C31H38O8","Ingredient_Smile": "CC1=C2C(C(C3(CCC(C(=C)C3C(C(C2(C)C)(CC1=O)O)OC(=O)C)OC(=O)C=CC4=CC=CC=C4)C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "355","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3r,5r)-3,5-dihydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)heptane3-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN009547","Ingredient_name": "(3r,5r)-3,5-dihydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)heptane3-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C27H38O11","Ingredient_Smile": "COC1=C(C=CC(=C1)CCC(CC(CCC2=CC(=C(C=C2)O)OC)OC3C(C(C(C(O3)CO)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5775","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5-cinnamoyl-10-aceyltaxicin i
{"Ingredient_id": "HBIN011497","Ingredient_name": "5-cinnamoyl-10-aceyltaxicin i","Alias": "NA","Ingredient_formula": "C31H38O8","Ingredient_Smile": "CC1=C2C(C(C3(CCC(C(=C)C3C(C(C2(C)C)(CC1=O)O)O)OC(=O)C=CC4=CC=CC=C4)C)O)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3698","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5-cinnamoyl-9-o-acetylphototaxicin i
{"Ingredient_id": "HBIN011501","Ingredient_name": "5-cinnamoyl-9-o-acetylphototaxicin i","Alias": "NA","Ingredient_formula": "C31H38O8","Ingredient_Smile": "CC1C(=O)CC2(C(C34C1(C2(C)C)C(C(C3(CCC(C4=C)OC(=O)C=CC5=CC=CC=C5)C)OC(=O)C)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14678","TCMID_id": "3697","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}